Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2013

01.01.2013 | Original Article

Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B

verfasst von: Melissa Wasserstein, James Godbold, Margaret M. McGovern

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Niemann-Pick disease (NPD) due to acid sphingomyelinase deficiency is a lipid storage disease resulting from the accumulation of sphingomyelin, predominantly within cells of the monocyte-macrophage system. In contrast to other lysosomal storage disorders, skeletal involvement in NPD has not been systematically studied.

Methods

Pediatric and adult NPD-B patients underwent medical histories and physical examinations, DEXA scans to measure bone mineral content (BMC), and bone mineral density (BMD) and computed tomography scan or MRI of the abdomen for spleen volume. Z and/or T scores were calculated for the DEXA results. For the pediatric patients adjusted mean BMC (g) and BMD (g/cm2) of the lumbar spine, hip, and femoral neck was compared to control subjects. For determination of the relationship between spleen volume and lumbar spine BMD Z score, linear correlation analyses were performed.

Results

Lumbar spine Z scores for pediatric patients ranged from 0.061 to -4.879. Statistically significant decreases were observed for the adjusted mean BMC and BMD at the lumbar spine, hip, and femoral neck between the pediatric NPD-B cohort and control subjects. Most NPD-B adults were osteopenic or osteoporotic at one or more sites according the WHO classification of BMD. In NPD-B patients, the degree of splenomegaly was inversely correlated with lumbar spine BMD Z scores.

Conclusion

Skeletal involvement is a common and previously unrecognized manifestation of NPD-B. The association between splenomegaly and BMD lends further support to spleen size as an indicator of disease severity.
Literatur
Zurück zum Zitat Arenz C (2010) Small molecule inhibitors of acid sphingomyelinase. Cell Physiol Biochem 26(1):1–8PubMedCrossRef Arenz C (2010) Small molecule inhibitors of acid sphingomyelinase. Cell Physiol Biochem 26(1):1–8PubMedCrossRef
Zurück zum Zitat Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ (2002) Bone complications in children with Gaucher disease. Br J Radiol 75:A37–A44PubMed Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ (2002) Bone complications in children with Gaucher disease. Br J Radiol 75:A37–A44PubMed
Zurück zum Zitat de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BCM (2009) Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int 20(12):2111-25 print de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BCM (2009) Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int 20(12):2111-25 print
Zurück zum Zitat Deegan PB, Pavlova E, Tindall J et al (2011) Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Med Jan 90(1):52–60 Deegan PB, Pavlova E, Tindall J et al (2011) Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Med Jan 90(1):52–60
Zurück zum Zitat DeMayo RF, Haims AH, McRae MC, Yang R, Mistry PK (2008) Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher’s disease. Am J Rheum 191:115-123 DeMayo RF, Haims AH, McRae MC, Yang R, Mistry PK (2008) Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher’s disease. Am J Rheum 191:115-123
Zurück zum Zitat Germain DP, Benistan K, Boutouyrie P (2005) Mutschler C (2005) Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease. Clin Genet 68(1):93–5PubMedCrossRef Germain DP, Benistan K, Boutouyrie P (2005) Mutschler C (2005) Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease. Clin Genet 68(1):93–5PubMedCrossRef
Zurück zum Zitat Goker-Alpan O (2011) Therapeutic approaches to bone pathology in Gaucher disease: past, present and future. Molec Genet Metab 104(4):438–447PubMedCrossRef Goker-Alpan O (2011) Therapeutic approaches to bone pathology in Gaucher disease: past, present and future. Molec Genet Metab 104(4):438–447PubMedCrossRef
Zurück zum Zitat Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford
Zurück zum Zitat Lin JH (1996) Biphosphonates: a review of their pharmacologic properties. Bone 18(2):72–85CrossRef Lin JH (1996) Biphosphonates: a review of their pharmacologic properties. Bone 18(2):72–85CrossRef
Zurück zum Zitat Makoto Y, Watanabe Y, Tokunaga Y et al (2008) Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease. Ped Int 49:959–965 Makoto Y, Watanabe Y, Tokunaga Y et al (2008) Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease. Ped Int 49:959–965
Zurück zum Zitat McGovern MM, Aron A, Brodie S, Desnick RJ, Wasserstein MP (2006) The natural history of Niemann Pick disease type A. Neurology 66(2):228–232PubMedCrossRef McGovern MM, Aron A, Brodie S, Desnick RJ, Wasserstein MP (2006) The natural history of Niemann Pick disease type A. Neurology 66(2):228–232PubMedCrossRef
Zurück zum Zitat McGovern MM, Wasserstein MP, Bembi B et al (2008) A cross sectional study of disease manifestations in Niemann Pick disease yype B. Pediatrics 122(2):e341–349PubMedCrossRef McGovern MM, Wasserstein MP, Bembi B et al (2008) A cross sectional study of disease manifestations in Niemann Pick disease yype B. Pediatrics 122(2):e341–349PubMedCrossRef
Zurück zum Zitat Mersebach H, Johansson JO, Rasmussen AK et al (2007) Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genet Med 12:812–8CrossRef Mersebach H, Johansson JO, Rasmussen AK et al (2007) Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genet Med 12:812–8CrossRef
Zurück zum Zitat Mistry PK, Liu J, Yang M et al (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage Mistry PK, Liu J, Yang M et al (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Zurück zum Zitat Mistry PK, Weinreb NJ, Kaplan P et al (2011) Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol Dis 46(1):66–72PubMedCrossRef Mistry PK, Weinreb NJ, Kaplan P et al (2011) Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol Dis 46(1):66–72PubMedCrossRef
Zurück zum Zitat NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795 CrossRef NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795 CrossRef
Zurück zum Zitat Roth AG, Drescher D, Yang Y et al (2009) Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angewandte Chemie 48:7560–7568PubMedCrossRef Roth AG, Drescher D, Yang Y et al (2009) Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angewandte Chemie 48:7560–7568PubMedCrossRef
Zurück zum Zitat Russell S, Crawford B, Morgane C, Diven D, Yarbor L (2011) Denosumab: a review of its pharmacology and clinical implications. Contemp Oncol 3(1) Russell S, Crawford B, Morgane C, Diven D, Yarbor L (2011) Denosumab: a review of its pharmacology and clinical implications. Contemp Oncol 3(1)
Zurück zum Zitat Sacre K, Lidove O, Giroux B et al (2010) Bone and joint involvement in Fabry disease. Scand J Rheum 39:171–174PubMedCrossRef Sacre K, Lidove O, Giroux B et al (2010) Bone and joint involvement in Fabry disease. Scand J Rheum 39:171–174PubMedCrossRef
Zurück zum Zitat Schuchman EH, Desnick RJ (2001) Niemann Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3589–3610 Schuchman EH, Desnick RJ (2001) Niemann Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3589–3610
Zurück zum Zitat Stevenson DA, Moyer-Mileur LJ, Murray M et al (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Ped 150(1):83–88CrossRef Stevenson DA, Moyer-Mileur LJ, Murray M et al (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Ped 150(1):83–88CrossRef
Zurück zum Zitat van Breemen MJ, de Fost M, Voerman JS et al (2007) Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta 1772(7):788–796PubMedCrossRef van Breemen MJ, de Fost M, Voerman JS et al (2007) Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta 1772(7):788–796PubMedCrossRef
Zurück zum Zitat Volders P, Van Hove J, Lories RJU et al (2002) Niemann-Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet 109(1):42–51PubMedCrossRef Volders P, Van Hove J, Lories RJU et al (2002) Niemann-Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet 109(1):42–51PubMedCrossRef
Zurück zum Zitat Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B (2002) Skeletal aspects of Gaucher disease: a review. Br J Rad 75:A2–A12 Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B (2002) Skeletal aspects of Gaucher disease: a review. Br J Rad 75:A2–A12
Zurück zum Zitat Wenstrup RJ, Bailey L, Grabowski GA et al (2004) Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. Blood 104:1253–1257PubMedCrossRef Wenstrup RJ, Bailey L, Grabowski GA et al (2004) Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. Blood 104:1253–1257PubMedCrossRef
Metadaten
Titel
Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B
verfasst von
Melissa Wasserstein
James Godbold
Margaret M. McGovern
Publikationsdatum
01.01.2013
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9503-0

Weitere Artikel der Ausgabe 1/2013

Journal of Inherited Metabolic Disease 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.